FindMyRecallSubscribe
Class II: temporary or reversible health riskCompleted

Sun Pharmaceutical Industries Zolpidem Tartrate Extended-Release Tablets Recall

Zolpidem Tartrate Extended-Release Tablets, USP 12

SUN PHARMACEUTICAL INDUSTRIES INC · Princeton, NJ

Risk level
Class II
Reported by FDA
Jan 31, 2024
Recall ID
D-0272-2024
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Zolpidem Tartrate Extended-Release Tablets starting Jan 18, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0272-2024 on Jan 31, 2024. Reason: CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment. Status: Completed.

Why it was recalled

CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Product description

Zolpidem Tartrate Extended-Release Tablets, USP 12.5mg, Rx Only, 100 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), INDIA, NDC 47335-308-88.

Lot numbers, UPCs & expiration codes

Lot #: DNE0893A Expires 07/31/2026

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0272-2024
Classification
Class II
Status
Completed
Recall initiated
Jan 18, 2024
FDA report date
Jan 31, 2024
Quantity
14,568 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC

Original FDA data

Every field from FDA enforcement report D-0272-2024, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Completed
Country
United States
Event ID
93820
Address
2 Independence Way
Code information
Lot #: DNE0893A Expires 07/31/2026
Postal code
08540-6620
Report date
Jan 31, 2024
Product type
Drugs
Recall number
D-0272-2024
Classification
Class II
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC
Product quantity
14,568 bottles
Reason for recall
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Zolpidem Tartrate Extended-Release Tablets, USP 12.5mg, Rx Only, 100 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), INDIA, NDC 47335-308-88.
Distribution pattern
Nationwide in the USA
Recall initiation date
Jan 18, 2024
Initial firm notification
Letter
Center classification date
Jan 25, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0272-2024, published Jan 31, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls